Pleiotropy-guided transcriptome imputation from normal and tumor tissues identifies candidate susceptibility genes for breast and ovarian cancer
Siddhartha Kar(University of Cambridge), Wei Zheng(Vanderbilt University), Håkan Olsson(Nokia (Finland)), Harvey A. Risch(University of New Haven), Allan Jensen(Danish Cancer Society), Jonathan P. Tyrer(University of Cambridge), Mikael Hartman(National University of Singapore), Ellen L. Goode(Mayo Clinic in Arizona), Jingmei Li(Genome Institute of Singapore), Claus Høgdall(Copenhagen University Hospital), Ailith Ewing(Cancer Research UK), Jenny Chang‐Claude(Universität Hamburg), Florian Heitz(Kliniken Essen-Mitte), Robert A. Vierkant(Mayo Clinic), Anna DeFazio(The University of Sydney), Thilo Dörk(Hannover Re (Germany)), Daniel Considine(University of Cambridge), Tomasz Huzarski(International Hereditary Cancer Center), Stacey J. Winham(Mayo Clinic), Marjorie J. Riggan(Duke Medical Center), Estrid Høgdall(University of Copenhagen), Padma Sheila Rajagopal(National Institutes of Health), Clara Bodelón(American Cancer Society), Susanne K. Kjær(Copenhagen University Hospital), Jennifer B. Permuth(Moffitt Cancer Center), Lukasz M. Szafron(National Institute of Oncology), Alvaro Barbeira(University of Chicago), Fernando Moreno(Hospital Clínico San Carlos), Georgia Chenevix‐Trench(QIMR Berghofer Medical Research Institute), George Fountzilas(Hellenic Cooperative Oncology Group), Arif B. Ekici(University Medical Center Groningen), Lambertus A. Kiemeney(Radboud University Nijmegen), Will Rosenow(University of Virginia), Susan J. Ramus(Cancer Institute of New South Wales), Э. К. Хуснутдинова(Russian Academy of Sciences), Jacques Simard(Université Laval), Emmanouil Saloustros(University of Thessaly), Rüdiger Klapdor(Medizinische Hochschule Hannover), Linda Titus(Dartmouth College), Felipe Segato Dezem(St. Jude Children's Research Hospital), Cheryl L. Thompson(Pennsylvania State University), Beth Y. Karlan(University of California, Los Angeles), Martin Köbel(University of Calgary), Stephanie Chen(Rutgers, The State University of New Jersey), Paolo Peterlongo(IFOM), Paolo Radice(IFOM), Taymaa May(University Health Network), Jasmine Plummer(St. Jude Children's Research Hospital), Clemens Liebrich(Fraunhofer Project Centre Wolfsburg), Peter Hillemanns(Medizinische Hochschule Hannover)
Cited by 17
Related Papers
Mutations of the BRAF gene in human cancer
|Nature|2002|10.7k
Average Risks of Breast and Ovarian Cancer Associated with BRCA1 or BRCA2 Mutations Detected in Case Series Unselected for Family History: A Combined Analysis of 22 Studies
|The American Journal of Human Genetics|2003|3.7k